IpsiHand System for Rehabilitation of the Arm and Hand After Stroke
Primary Purpose
Stroke, Hemiparesis
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
IpsiHand Treatment
Sponsored by
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Hemiparesis, Rehabilitation, Upper Extremity, Neurological Rehabilitation, Neuronal Plasticity, Brain-Computer Interfaces, Robotics
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of stroke(s), with most recent stroke at least 6 months prior to study start (can be ischemic or hemorrhagic)
- PROM: Full extension of digits 2 and 3 at MPs, PIPs, and DIPs
- English speaking
- Intact cognition to provide informed consent
- Intact language skills to comprehend and follow directions
- Experiencing difficulty performing ADLs with affected upper limb
Upper extremity Botox allowable, but not required
- Botox users must continue regimen at regular intervals for duration of study
- Botox users will provide clinic note for each injection (date, dose, and muscle location)
- Botox + Study Schedule
- At study initiation, Botox injection will occur between 3-7 days prior to baseline measurement and initiation of device use
- Repeat Botox injections must be completed at least 3 days prior to any administration of the outcome measures
Exclusion Criteria:
- Concurrent participation in another study
- Co-morbid orthopedic condition/pain limiting functional use of the impaired upper limb
- History of neurological disorder other than stroke
- Botox user unable to comply with above noted requirements
- Ongoing physical or occupational therapy addressing the upper limb
- Ongoing electric stimulation or other rehabilitative devices (e.g. robotics, virtual reality) to upper limb
- Cognitive impairment: Short Blessed Test Score 9
- Significant spasticity: Modified Ashworth Scale score 3 at the elbow
- Significant hemispatial neglect: Mesulam Cancellation Test 3 unilaterally
- Insufficient Strength: Motricity Index score for shoulder abduction 18
- Significantly impaired sensation of impaired upper limb: National Institutes of Health Stroke Scale - Item 8 (Sensory) score of 2
- History of cranioplasty
- History of seizure disorder
- No changes to usual exercises, splint use, or oral baclofen/anti-spasticity medication use during trial
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
IpsiHand Treatment
Arm Description
All participants will receive treatment with IpsiHand device
Outcomes
Primary Outcome Measures
Fugl-Meyer Assessment of Motor Recovery after Stroke for Upper Extremity
The Fugl-Meyer is a scale that measures capacity of the arm. There are 33 items that evaluate reflexes, active movement, grasp patterns, speed, and coordination of the arm and hand. Each item is scored from 0-2, with a maximum total score of 66. Higher scores indicate better performance.
Secondary Outcome Measures
Action Research Arm Test
The ARAT is a scale that measures activity participation of the arm. There are 19 items that several types of grasps, grips, pinches, and gross movements of the arm and hand. Each item is scored from 0-3, with a maximum total score of 57. Higher scores indicate better performance.
Box and Block Test
The Box and Block Test measures the number of blocks a participant can pick up and place over a patrician in 1 minute. The number of blocks successfully moved are counted and a higher number indicates better performance.
Full Information
NCT ID
NCT04123808
First Posted
October 10, 2019
Last Updated
August 4, 2020
Sponsor
Columbia University
Collaborators
Neurolutions, Inc.
1. Study Identification
Unique Protocol Identification Number
NCT04123808
Brief Title
IpsiHand System for Rehabilitation of the Arm and Hand After Stroke
Official Title
Dosing Effects of an Upper Extremity Rehabilitation Program Using a Brain-Computer Interface Mediated Robotic Hand Orthosis for Chronic Stroke Patients: IpsiHand System
Study Type
Interventional
2. Study Status
Record Verification Date
August 2020
Overall Recruitment Status
Withdrawn
Why Stopped
Closed by sponsor
Study Start Date
December 2, 2019 (Actual)
Primary Completion Date
June 30, 2020 (Actual)
Study Completion Date
June 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Columbia University
Collaborators
Neurolutions, Inc.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aims to assess whether the NeuroLutions Upper Extremity Rehabilitation System (known as IpsiHand) will help stroke patients regain strength and functional movements in their arm. The IpsiHand system involves using a hand robotic device that is controlled by brain waves, known as a Brain-Computer Interface (BCI). By using the device, participants will be harnessing brainwaves from the side of their brain not affected by stroke to control the robotic device on the hand that is weaker from the stroke.
Detailed Description
This trial aims to assess the effectiveness of the NeuroLutions Upper Extremity Rehabilitation System, known as IpsiHand, on functional motor recovery and neuroplasticity for chronic stroke survivors with hemiparesis (N=27). The IpsiHand system involves a Brain-Computer Interface (BCI) as a control for a robotic hand orthosis. Participants will complete 16-32 weeks of home therapy with the IpsiHand system.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke, Hemiparesis
Keywords
Stroke, Hemiparesis, Rehabilitation, Upper Extremity, Neurological Rehabilitation, Neuronal Plasticity, Brain-Computer Interfaces, Robotics
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
An occupational therapist independent to the study will review and score 2 outcome measures (Fugl-Meyer and Action Research Arm Test). The study coordinator will randomize the order of the videos for each participant, so that the outcome assessor will not know which time point they are scoring. In other words, the video-outcome assessor will be blinded to the order of the assessments as they are scoring them but will not be blinded to the intervention as all participants will be receiving the same intervention.
Allocation
N/A
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
IpsiHand Treatment
Arm Type
Experimental
Arm Description
All participants will receive treatment with IpsiHand device
Intervention Type
Device
Intervention Name(s)
IpsiHand Treatment
Intervention Description
The IpsiHand system utilizes a Brain-Computer Interface (BCI) as a control for a robotic hand orthosis donned on the affected upper extremity as participants are guided through a rehabilitation program on a tablet. Participants will complete 16-32 weeks of home therapy with the IpsiHand system. Motor function of their impaired upper extremity will be evaluated at baseline, at 4-week intervals, and 3 months post no-device use, to track progress.
Primary Outcome Measure Information:
Title
Fugl-Meyer Assessment of Motor Recovery after Stroke for Upper Extremity
Description
The Fugl-Meyer is a scale that measures capacity of the arm. There are 33 items that evaluate reflexes, active movement, grasp patterns, speed, and coordination of the arm and hand. Each item is scored from 0-2, with a maximum total score of 66. Higher scores indicate better performance.
Time Frame
Baseline through 3 months post no device use
Secondary Outcome Measure Information:
Title
Action Research Arm Test
Description
The ARAT is a scale that measures activity participation of the arm. There are 19 items that several types of grasps, grips, pinches, and gross movements of the arm and hand. Each item is scored from 0-3, with a maximum total score of 57. Higher scores indicate better performance.
Time Frame
Baseline through 3 months post no device use
Title
Box and Block Test
Description
The Box and Block Test measures the number of blocks a participant can pick up and place over a patrician in 1 minute. The number of blocks successfully moved are counted and a higher number indicates better performance.
Time Frame
Baseline through 3 months post no device use
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of stroke(s), with most recent stroke at least 6 months prior to study start (can be ischemic or hemorrhagic)
PROM: Full extension of digits 2 and 3 at MPs, PIPs, and DIPs
English speaking
Intact cognition to provide informed consent
Intact language skills to comprehend and follow directions
Experiencing difficulty performing ADLs with affected upper limb
Upper extremity Botox allowable, but not required
Botox users must continue regimen at regular intervals for duration of study
Botox users will provide clinic note for each injection (date, dose, and muscle location)
Botox + Study Schedule
At study initiation, Botox injection will occur between 3-7 days prior to baseline measurement and initiation of device use
Repeat Botox injections must be completed at least 3 days prior to any administration of the outcome measures
Exclusion Criteria:
Concurrent participation in another study
Co-morbid orthopedic condition/pain limiting functional use of the impaired upper limb
History of neurological disorder other than stroke
Botox user unable to comply with above noted requirements
Ongoing physical or occupational therapy addressing the upper limb
Ongoing electric stimulation or other rehabilitative devices (e.g. robotics, virtual reality) to upper limb
Cognitive impairment: Short Blessed Test Score 9
Significant spasticity: Modified Ashworth Scale score 3 at the elbow
Significant hemispatial neglect: Mesulam Cancellation Test 3 unilaterally
Insufficient Strength: Motricity Index score for shoulder abduction 18
Significantly impaired sensation of impaired upper limb: National Institutes of Health Stroke Scale - Item 8 (Sensory) score of 2
History of cranioplasty
History of seizure disorder
No changes to usual exercises, splint use, or oral baclofen/anti-spasticity medication use during trial
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joel Stein, MD
Organizational Affiliation
Columbia University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28550098
Citation
Bundy DT, Souders L, Baranyai K, Leonard L, Schalk G, Coker R, Moran DW, Huskey T, Leuthardt EC. Contralesional Brain-Computer Interface Control of a Powered Exoskeleton for Motor Recovery in Chronic Stroke Survivors. Stroke. 2017 Jul;48(7):1908-1915. doi: 10.1161/STROKEAHA.116.016304. Epub 2017 May 26.
Results Reference
background
PubMed Identifier
29761128
Citation
Cervera MA, Soekadar SR, Ushiba J, Millan JDR, Liu M, Birbaumer N, Garipelli G. Brain-computer interfaces for post-stroke motor rehabilitation: a meta-analysis. Ann Clin Transl Neurol. 2018 Mar 25;5(5):651-663. doi: 10.1002/acn3.544. eCollection 2018 May.
Results Reference
background
PubMed Identifier
24136129
Citation
Zeiler SR, Krakauer JW. The interaction between training and plasticity in the poststroke brain. Curr Opin Neurol. 2013 Dec;26(6):609-16. doi: 10.1097/WCO.0000000000000025.
Results Reference
background
Learn more about this trial
IpsiHand System for Rehabilitation of the Arm and Hand After Stroke
We'll reach out to this number within 24 hrs